Home/Hedge Fund Intelligence/Amylyx Pharmaceuticals, Inc.
Nasdaq: AMLXStockForm 13F30 Jun 2026

Hedge funds that hold Amylyx Pharmaceuticals, Inc. Nasdaq: AMLX

CUSIP 03237H101 · who reports it, how much, and how much it matters to them

32 of the 720 hedge fund managers we track reported shares of Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) on Form 13F for 30 June 2026. Between them they reported USD 331m. The largest position belongs to Perceptive Advisors, at USD 150m. The manager with the most riding on it is Almitas Capital, where it is 4.2% of the reported book.

Managers reporting it32of 720 we track
Value they reportUSD 331mshares only, 30 Jun 2026
Funds they run577with a file on PPLI.com
Largest positionUSD 150mPerceptive Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight4.2%Almitas Capital

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

32 managers, USD 331m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Amylyx Pharmaceuticals, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Perceptive Advisors6 funds on PPLI.comUSD 150m2.2%
2Adage Capital Management1 fund on PPLI.comUSD 34m0.0%
3683 Capital Management2 funds on PPLI.comUSD 23m1.1%
4Almitas Capital2 funds on PPLI.comUSD 18m4.2%
5Boxer Capital Management1 fund on PPLI.comUSD 14m1.1%
6Great Point Partners2 funds on PPLI.comUSD 13m2.4%
7Balyasny Asset Management25 funds on PPLI.comUSD 12m0.0%
8Two Sigma Investments35 funds on PPLI.comUSD 11m0.0%
9Rock Springs Capital Management2 funds on PPLI.comUSD 9m0.4%
10HighVista Strategies27 funds on PPLI.comUSD 6.9m1.6%
11Logos Global Management1 fund on PPLI.comUSD 6.3m0.3%
12Cormorant Asset Management1 fund on PPLI.comUSD 3.6m0.2%
13Walleye Capital8 funds on PPLI.comUSD 3.4m0.0%
14Orbimed Advisors1 fund on PPLI.comUSD 3.3m0.1%
15Citadel Advisors32 funds on PPLI.comUSD 3.2m0.0%
16D. E. Shaw & Co.15 funds on PPLI.comUSD 3.1m0.0%
17Acuta Capital Partners2 funds on PPLI.comUSD 3m2.1%
18Alpha Wave Global1 fund on PPLI.comUSD 2.8m0.0%
19PFM Health Sciences3 funds on PPLI.comUSD 2.6m0.2%
20Lighthouse Investment Partners190 funds on PPLI.comUSD 2.2m0.1%
21Campbell & Company Investment Adviser8 funds on PPLI.comUSD 1.8m0.1%
22Schonfeld Strategic Advisors30 funds on PPLI.comUSD 1.2m0.0%
23Hudson Bay Capital Management8 funds on PPLI.comUSD 898,0000.0%
24Aquatic Capital Management3 funds on PPLI.comUSD 708,0000.0%
25Boothbay Fund Management2 funds on PPLI.comUSD 648,0000.0%
26Tudor Investment Corporation10 funds on PPLI.comUSD 636,0000.0%
27Jain Global1 fund on PPLI.comUSD 517,0000.0%
28Graham Capital Management18 funds on PPLI.comUSD 222,0000.0%
29Magnetar Financial93 funds on PPLI.comUSD 211,0000.0%
30Brevan Howard Capital Management39 funds on PPLI.comUSD 209,0000.0%
31Fulcrum Asset Management LLP7 funds on PPLI.comUSD 82,2800.0%
32The Quarry1 fund on PPLI.comUSD 2,4960.0%
Next: where it matters most
Where it matters most

For Almitas Capital it is 4.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Almitas CapitalUSD 18m4.2%
2Great Point PartnersUSD 13m2.4%
3Perceptive AdvisorsUSD 150m2.2%
4Acuta Capital PartnersUSD 3m2.1%
5HighVista StrategiesUSD 6.9m1.6%
6683 Capital ManagementUSD 23m1.1%
7Boxer Capital ManagementUSD 14m1.1%
8Rock Springs Capital ManagementUSD 9m0.4%
9Logos Global ManagementUSD 6.3m0.3%
10PFM Health SciencesUSD 2.6m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Amylyx Pharmaceuticals, Inc.

What is the ticker symbol of Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. trades under the symbol AMLX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 03237H101.

Which hedge funds own Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX)?

32 of the 720 hedge fund managers PPLI.com tracks reported Amylyx Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 150m), Adage Capital Management (USD 34m), 683 Capital Management (USD 23m), Almitas Capital (USD 18m) and Boxer Capital Management (USD 14m).

How many hedge funds hold Amylyx Pharmaceuticals, Inc.?

32 managers in our coverage reported it, and between them they run 577 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Amylyx Pharmaceuticals, Inc.?

Almitas Capital, where the position was 4.2% of the reported 13F book at 30 June 2026.

Does this show who is short Amylyx Pharmaceuticals, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Amylyx Pharmaceuticals, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.